In this scenario SET binding protein 1 (SETBP1) has attracted a lot of interest as a new oncogene and potential marker, in addition to its involvement in the Schinzel-Giedon syndrome (SGS). This evidence concerns the gene SETBP1 and Schinzel-Giedion syndrome.